Orexigen Therapeutics, Inc. v. Actavis Labs. FL, Inc.
District Court, D. Delaware
1Opinion of the Court
ANDREWS, U.S. DISTRICT JUDGE
*797Plaintiff brought this patent infringement action on June 3, 2015, alleging that Defendant had infringed seven of Plaintiff's patents by filing Abbreviated New Drug Application ("ANDA") No. 208043 seeking to enter the market with a generic version of Plaintiff's Contrave product. (D. I. 1). On April 15, 2016, Plaintiff filed a First Amended Complaint alleging infringement of four patents. (D.I. 47). Prior to trial, Plaintiff withdrew one of the four patents (see D.I. 182), leaving three patents-in-suit: U.S. Patent Nos. 7,462,626 ("the '626 patent"), 7,375,111…
2Cases cited37 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Global-Tech Appliances, Inc. v. SEB S. A.Supreme Court of the United States · 2011
32 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Nalpropion Pharmaceuticals v. Actavis Laboratories Fl, Inc.Court of Appeals for the Federal Circuit · 2019
- Cephalon, Inc. v. Slayback Pharma Limited Liability CompanyDistrict Court, D. Delaware · 2020
- JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITEDDistrict Court, D. New Jersey · 2023
- Roche Diagnostics Corporation v. Meso Scale Diagnostics, LLCDistrict Court, D. Delaware · 2020